Tirofiban hydrochloride is the first non-polypeptide platelet membrane GP IIb/IIIa receptor antagonist.

Undoubtedly, increasing the ratio of pyruvate carboxylation can improve the utilization rate of carbon source, that is, can improve the yield of malic acid.

Compound Dextran 40 injection will become the preferred variety of blood volume expanders and will be brilliant in the field of plasma replacement!

The WHO ranked China's vaccine regulatory system at a functional level of maturity according to the WHO's global classification system for national medical product regulatory authorities.

In order to improve the company's environmental benefits, economic benefits and reduce pollutant emissions, in accordance with the notice of the Shaanxi Provincial Department of Ecology and Environmen

Tirofiban hydrochloride is a chemically synthesized non-peptide drug, which has two effects.

The difference in the physiological functions between D-malic acid and L-malic acid leads to their different uses in various aspects of social industry.

The consistency evaluation of L-Alanyl-L-glutamine Injection from Xi’an Wanlong Pharmaceutical was approved.

Compound Dextran 40 Injection used in hand and foot surgery can effectively expand the blood vessels of patients, improve blood circulation, and facilitate the recovery of hand and foot affected areas

Tirofiban hydrochloride is a reversible non-peptide platelet GP IIb/IIIa receptor antagonist, developed by Merck in the United States.

There are two aseptic processing for aseptic injections in pharmaceutical industry,terminal sterilization process and aseptic processing.

Malic acid (2-hydroxybutanedioic acid, C4H6O5) is a white, odorless, crystalline solid. In contrast to other fruit acids, it is very hygroscopic and has a tendency to lump. Malic acid is a dicarboxyli

Due to is biocompatibility, biodegradability and low toxicity, Dextran has a wide application area within life science and the medical industry.

Low molecular weight Dextran (LMWD) can be used as a flushing medium instead of contrast agents in coronary heart disease intravascular imaging.

Dextran, 6% dextran isotonic saline solution is a commonly used polysaccharide plasma substitute.